Seeking Alpha

Shares of microcap biotech firm Alexza Pharmaceuticals (ALXA -14.6%) get slammed after the FDA...

Shares of microcap biotech firm Alexza Pharmaceuticals (ALXA -14.6%) get slammed after the FDA says it needs an additional three months to complete its review of the company's new drug application for Adasuve, a schizophrenic and bipolar disorder treatment.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs